Lifecore Biomedical, Inc. LFCR Share-Based Payment Award Options Outstanding - Number
Share-Based Payment Award Options Outstanding - Number at other companies
Other financials
Where this comes from
Reported directly by Lifecore Biomedical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber.
The official record: Lifecore Biomedical, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Lifecore Biomedical, Inc.'s share-based payment award options outstanding - number.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Lifecore Biomedical, Inc.'s share-based payment award options outstanding - number?
- Lifecore Biomedical, Inc. (LFCR) reported share-based payment award options outstanding - number of 1.3M in Q1 2026.
- What is the long-term trend for Lifecore Biomedical, Inc.'s share-based payment award options outstanding - number?
- Over 2 years (2023 to 2026), Lifecore Biomedical, Inc.'s share-based payment award options outstanding - number has grown at a -25.8% compound annual growth rate (CAGR), from 2.4M to 1.3M.
- What does share-based payment award options outstanding - number mean?
- This is the total count of stock options granted to employees and directors that remain unexercised at the reporting date. It reflects the total volume of potential equity claims currently held by the workforce. This metric is a key component in calculating fully diluted share counts.